Although the numbers of CD14+HLA-DRlow/− monocytes were not significantly different among the subtypes of lymphoma, patients with a higher International Prognostic Index score had statistically a higher percentage of CD14+HLA-DRlow/− monocytes (Figure 2e). This evidence concerns the gene CD14 and lymphoma.